Biodexa Pharmaceuticals Plc (BDRX)

1.41 +0.21 (+17.50%) USD  |  NASDAQ  |  Aug 25, 10:47
More

Biodexa Pharmaceuticals Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
June 29, 2026 --
March 30, 2026 --
April 21, 2025 --
Date Value
December 30, 2024 --
June 04, 2024 --
February 08, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade
BioNTech SE Upgrade
Silence Therapeutics Plc Upgrade
Autolus Therapeutics Plc Upgrade